You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Poly I-C

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioma, Malignant Trial in Durham (Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine, Hiltonol)

Not yet recruiting
  • Glioma, Malignant
  • Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine
  • Hiltonol
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke University
Jan 19, 2023

Patient Satisfaction Trial in Cairo (RPD with PEEK framework, RPD with metallic framework)

Active, not recruiting
  • Patient Satisfaction
  • RPD with PEEK framework
  • RPD with metallic framework
  • Cairo, Egypt
    Faculty of Dentistry
Nov 14, 2022

Thin Gingival Biotype Trial in Baghdad (Platelets Rich Fibrin (i-PRF / C-PRF))

Completed
  • Thin Gingival Biotype
  • Platelets Rich Fibrin (i-PRF / C-PRF)
  • Baghdad, Alresafa, Iraq
    University of Baghdad
Nov 11, 2022

Myelofibrosis, Essential Thrombocythemia, MPN Trial in New York (Peptide-based vaccine, Poly ICLC)

Not yet recruiting
  • Myelofibrosis
  • +2 more
  • Peptide-based vaccine
  • Poly ICLC
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jun 7, 2022

Thin Gingival Biotype Trial in Cairo (Vit C, injectable PRF)

Not yet recruiting
  • Thin Gingival Biotype
  • Vit C
  • injectable PRF
  • Cairo, Elmanil, Egypt
    Faculty of dentistry Cairo University
Apr 22, 2023

Healthy Trial in Groningen (BI 764198 (C-14) (approach 1), BI 764198 (C-14) (approach 2))

Recruiting
  • Healthy
  • BI 764198 (C-14) (approach 1)
  • BI 764198 (C-14) (approach 2)
  • Groningen, Netherlands
    ICON
May 8, 2023

Metastatic Castration-resistant Prostate Cancer Trial in United States (drug, radiation, device)

Completed
  • Metastatic Castration-resistant Prostate Cancer
  • NKTR-214 (Cohort A)
  • +6 more
  • Los Angeles, California
  • +5 more
Nov 10, 2022

Adverse Effects, Ascorbic Acid, Oxidative Stress Trial in Mollet Del Vallès (1gr. Vitamine C, 1gr Placebo, control group)

Completed
  • Adverse Effects
  • +2 more
  • 1gr. Vitamine C
  • +2 more
  • Mollet Del Vallès, Barcelona, Spain
    Medicina Esportiva i Osteopatia
Oct 29, 2023

Infection, Meningococcal Trial in Seoul (Meningococcal(Groups A, C, W-135, X, and Y) Conjugate Vaccine, Meningococcal(Groups A,

Not yet recruiting
  • Infection, Meningococcal
  • Meningococcal(Groups A, C, W-135, X, and Y) Conjugate Vaccine
  • Meningococcal(Groups A, C, Y, and W-135) Conjugate Vaccine
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Feb 12, 2023

Tauopathies Trial in Philadelphia (drug, diagnostic test, behavioral)

Active, not recruiting
  • Tauopathies
  • 11C-HY-2-15 PET
  • +3 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Sep 6, 2023

Healthy Adults Trial in Créteil (Solo 0.3 group, Solo 1 group, Solo 3 group)

Recruiting
  • Healthy Adults
  • Solo 0.3 group
  • +5 more
  • Créteil, France
  • +2 more
Sep 9, 2022

Degenerative Disc Disease Trial (TG-C High Dose, TG-C Mid Dose, TG-C Low Dose)

Not yet recruiting
  • Degenerative Disc Disease
  • TG-C High Dose
  • +3 more
  • (no location specified)
Nov 17, 2023

Advanced NSCLC With KRAS G12C Mutation Trial in New York (Sotorasib, Ladarixin)

Not yet recruiting
  • Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
  • New York, New York
    NYU Langone Health
Apr 4, 2023

HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in Seattle (HER-2/neu peptide vaccine,

Completed
  • HER2-positive Breast Cancer
  • +7 more
  • HER-2/neu peptide vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Feb 4, 2020

Meningioma Trial in San Francisco (drug, procedure, other)

Not yet recruiting
  • Meningioma
  • Hyperpolarized carbon C 13 pyruvate
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Aug 23, 2023

Healthy Trial (BI 1810631 (C-14) formulation 1, BI 1810631, BI 1810631 (C-14) formulation 2)

Not yet recruiting
  • Healthy
  • BI 1810631 (C-14) formulation 1
  • +2 more
  • (no location specified)
May 25, 2023

Clinical Performance Evaluation of the C2i Test

Not yet recruiting
  • Muscle Invasive Bladder Cancer
  • C2i-WGS-MRD Test
  • (no location specified)
May 5, 2023

Advanced Solid Tumor Trial in Shanghai (SY-5933)

Recruiting
  • Advanced Solid Tumor
  • Shanghai, China
    Shanghai Pulmonary Hospital
Aug 16, 2023

Advanced or Metastatic Solid Tumor, KRAS G12C Mutation Trial in Changsha (BEBT-607Tablets)

Recruiting
  • Advanced or Metastatic Solid Tumor
  • KRAS G12C Mutation
  • Changsha, Hunan, China
    Xiangya Hospital of Central South University
Nov 2, 2023

Healthy Trial in Groningen (BI 1291583 mixed with [C-14] BI 1291583)

Not yet recruiting
  • Healthy
  • BI 1291583 mixed with [C-14] BI 1291583
  • (no location specified)
Apr 17, 2023

Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial (PHA-022121 low dose, PHA-022121 medium

Recruiting
  • Hereditary Angioedema
  • +11 more
  • PHA-022121 low dose
  • +3 more
  • Birmingham, Alabama
  • +7 more
Dec 5, 2022

Colon Cancer, Colorectal Cancer Trial in Houston (MRTX849, Irinotecan, Cetuximab)

Not yet recruiting
  • Colon Cancer
  • Colorectal Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2023

MDS Trial in Saint Louis (DEC-C, MyeloSeq-HD)

Recruiting
  • Myelodysplastic Syndromes
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 18, 2023

Solid Tumor Trial in Kashiwa-shi, Matsuyama-shi, Koto-Ku (M1-c6v1)

Not yet recruiting
  • Solid Tumor
  • M1-c6v1
  • Kashiwa-shi, Chiba, Japan
  • +2 more
Sep 19, 2023

Colorectal Cancer, Esophagus Cancer, Gastric Cancer Trial in Hangzhou (CEA-targeted CAR-T cells)

Recruiting
  • Colorectal Cancer
  • +6 more
  • CEA-targeted CAR-T cells
  • Hangzhou, Zhejiang, China
  • +1 more
Sep 18, 2023